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a  b  s  t  r  a  c  t
The aims of this study were to investigate the genotypes of hepatitis B virus and to iden-
tify  the precore G1896A and basal core promoter A1762T/G1764A mutations in HBsAg and
anti-HBc-positive  patients. Eighty-three asymptomatic individuals, three with acute hep-
atitis  B and 33 with chronic hepatitis B referred to viral hepatitis centers in the State of
Alagoas, Brazil were analyzed according to their viral load, HBeAg/anti-HBe proﬁle and
alanine  aminotransferase serum level. The genotypes identiﬁed were:  A (92.5%), C (5%), D
(1.25%) and F (1.25%). The precore mutation was detected in 3.8% of sequences and basal core
promoter mutation in 52.4%. These were identiﬁed in 45.45% of the asymptomatic individ-Alagoas
Brazil
uals  and 54.55% of the patients with chronic hepatitis, irrespective of viral load and alanine
aminotransferase  serum level. In genotype C, only the basal core promoter mutation was
identiﬁed  and no mutations were identiﬁed in genotypes D and F.
Crown Copyright © 2013 Published by Elsevier Editora Ltda. 
central-western regions of the country.
Este é um artigo Open Access sob a licença de CC BY-NC-NDThe hepatitis B virus (HBV) has a circular DNA genome with
about  3200 nucleotides (nts), which consists of a full-length of
negative  strand and a shorter positive strand.1 The lack of a
revision  mechanism involving DNA polymerase activity dur-
ing the process of reverse transcription of pre-genomic RNA
favors  the appearance of speciﬁc mutations.2HBV has been classiﬁed into ten genotypes (A–J). In Brazil,
the  genotype distribution is heterogeneous, reﬂecting the
diversity  of the Brazilian population. Type A is predominant,3
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http://dx.doi.org/10.1016/j.bjid.2013.03.011while type F is most frequent among the indigenous popula-
tion  of the Amazon region.4 Types B and C have been described
most  frequently among populations of Asian ethnicity,5 while
type  D has been described among individuals of Italian
descent, most frequently in the southeastern, southern and
5,6, PE 50850-040, Brazil.
The transition from guanine to adenine in the nucleotide
1896 creates a premature stop codon in the precore region
that  prevents synthesis of the HBV e antigen (HBeAg), thereby
Este é um artigo Open Access sob a licença de CC BY-NC-ND
















































ab r a z j i n f e c t d i s .
educing virus replication.6 On the other hand, the presence
f  thymine in nt 1858, forming a base pair with the adenine in
t 1896, makes the encapsidation signal of the pre-genomic
NA stronger. This increases the efﬁciency of the replication,
espite  the presence of anti-HBe. The genotypes B, C, D and
 have thymine in nt 1858, F has cytosine or thymine and A
enerally  has cytosine. This explains the greater frequency of
his  mutation in the genotypes B, C, D, E and F.7
Mutations in the basal core promoter (BCP) region (A1762T
nd  G1764A) have been described independently of serocon-
ersion  of HBeAg and are common in different genotypes.8
The aims of this study were to investigate the genotypes of
BV  and the presence of precore and BCP mutations among
BsAg  and anti-HBc-positive patients, evaluated according to
heir viral load, HBeAg/anti-HBe proﬁle and alanine amino-
ransferase (ALT) serum level.
Between September 2006 and October 2007, 119 patients
eferred to viral hepatitis centers in the State of Alagoas (74
en  and 45 women) who were serologically positive for HBsAg
nd  anti-HBc were  selected. There were 83 asymptomatic indi-
iduals, three with acute hepatitis B, and 33 with chronic
epatitis B, with histological conﬁrmation.
The patients signed a free and informed consent statement
nd  ﬁlled out a questionnaire to provide demographic data.
lood  was  collected by means of venous puncture, without
nticoagulant, in order to obtain serum.
This study was  approved by the Research Ethics Committee
f  the Federal University of Alagoas (UFAL), in accordance with
esearch  protocol no. 000906/2005-98, on March 16, 2005.
ALT  was  assayed using a commercial kit in accordance with
he  manufacturer’s instructions (Abbott Laboratories, Brazil).
ssays  were  considered normal when the concentration was
ess  than 1.5 times the normal upper limit (55 U/L) and high
hen  it was  greater than or equal to 1.5 times the normal
pper  limit.9
The HBeAg/anti-HBe markers were investigated by means
f  a commercial immunoenzymatic assay (Symbiosis Diag-
óstica  Ltda, São Paulo, Brazil).
Extraction of the viral genome and partial ampliﬁcation of
he  S gene and precore region were  performed in accordance
ith  the protocol of Sitnik et al.5
The viral load was  determined in accordance with the pro-
ocol  for extraction followed by ampliﬁcation of the core region
f  the virus genome that were  developed by Kaneko et al.10
Analysis of the genotypes was  performed by comparing
he sequences obtained with the sequences for different HBV
enotypes  deposited in Genbank. The classiﬁcation of the
enotypes  was  conﬁrmed using the genotyping tool available
rom  the NCBI website (http://www.ncbi.nlm.nih.gov/projects/
enotyping/formpage.cgi). Mutations were identiﬁed by align-
ng the nt sequences obtained from the study compared with
 sequence for the wild virus. For these analyses, the EditSeq
nd  Megalign programs  from the DNAstar software package
ere  used (Lasergene Inc., Madison, WI,  USA).
esults  and  discussionn Brazil, the literature on the genotypes A, D and F is still
parse  and, the present study is the ﬁrst to describe genotypes
nd  HBV mutations among patients from Alagoas, Brazil.3;1 7(6):704–706  705
Among  the 119 patients, the mean age was  35 ± 10.9 years
and  Asian ethnicity with 2.5% (3/119). The S gene fragment
of  HBV DNA was  detected in 70.6% (84/119) patients and
genotypes were identiﬁed in 95.2% (80/84) of the sequences.
Genotype A was  identiﬁed in 92.5% (74/80), C in 5% (4/80), D in
1.25% (1/80) and F in 1.25% (1/80). One patient with infection
due  to genotype A and other two infected by type C belonged
to  Asian ethnicity.
The  greater frequency of infection due to genotype A
found  in this study has also been identiﬁed in Salvador,11
Pernambuco12 and the Amazon region.4 Genotype A is always
detected  in Brazilian studies and sometimes is predomi-
nantly associated with genotype D6,13 and sometimes with
type  F.11,16 However, in Alagoas, genotype A was  accompa-
nied by genotype C, emphasizing that the infection due to
genotype  A was also found in a patient of Asian ethnic-
ity.
The detection of type C was  an unexpected ﬁnding, consid-
ering  that this type predominates in Asia and that population
of  Asian ethnicity living in Alagoas is only 0.1% of the whole
population, according to the Brazilian Institute for Geography
and  Statistics.14
The low frequency of genotype D in Alagoas is similar to
data  from Ribeiro et al.11 who did not identify any infection by
this  genotype in 76 patients investigated in Salvador, Brazil.
It  is predominant in the southern and southeastern regions,
which  are areas where Italian immigration took place,6,11,13
and its frequency is lower in the northeastern region.11,12
The genotype F did not follow the national distribution pat-
tern,  in which infections due to this type are more  frequent in
the northern and northeastern regions.4,11
One of the cases had the infection due to genotype D
and  another had the type F were identiﬁed in asymptomatic
individuals with normal ALT serum level. The former was
HBeAg  negative and had a viral load of 3 × 1010 genomes/mL
and the latter was anti-HBe positive and had a viral load
3  × 102 genomes/mL.
The nt polymorphism that occurs naturally over the course
of  HBV infections is responsible for the appearance of spe-
ciﬁc  mutations in the viral genome. The precore mutations
G1896A/C1899A and BCP mutations A1762T/G1764A are the
most  frequent types and, for this reason, they have been inten-
sively  investigated.8,15
The presence of thymine/cytosine at position 1858 was
investigated in 31 sequences, of which 26 were  genotype A,
three  were C, one was  D, and one was  F. It was  identiﬁed in 50%
(13/26)  of the sequences of genotype A and in 33.3% (1/3) of the
genotype  C sequences. Thymine was  absent in the genotypes
D  and F.
The  precore mutation G1896A was investigated in 31
sequences and was  identiﬁed in one patient with chronic hep-
atitis  due to genotype A. This individual presented a viral load
of  3 × 1012 copies/mL, high ALT serum level, HBeAg-negative
and anti-HBe-positive.
The BCP mutations A1762T/G1764A were investigated in
26  sequences, of which 21 were genotype A, three were  C,
one  was  D and one was F. These mutations were  identiﬁed
in  52.4% (11/21) of the infections due to genotype A, which
45.45%  (5/11) were asymptomatic individuals and 54.55% (6/11)
patients  with chronic hepatitis. They were identiﬁed in 33.3%
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(1/3) of the infections due to genotype C and no mutations
were  identiﬁed in genotypes D and F.
The genotype A generally has cytosine (C) at position 1858,
according  to the studies by De Castro et al.16 and Sitnik et al.,5
who  found cytosine in 100% and 90% of the isolates of this
genotype, respectively. However, in our study, cytosine was
presented  in 50% of the isolates. This is close to the frequency
of  68.4% found by Rezende et al.6
Circulation of the precore mutation G1896A of genotype A
is  rare and shows a relationship with the presence of cytosine
in  nt 1858.5,6,16 In our study, we also found a low frequency
of this mutation, although cytosine was  present in 50% of the
sequences  of genotype A. The identiﬁcation of a precore muta-
tion  in one patient with high viral load and anti-HBe positive
can  be due to replacement of cytosine by thymine in nt 1858,
although  this substitution could not be identiﬁed.
The frequency of the BCP mutation A1762T/G1764A found
in  genotype A, i.e. 52.4% was  comparable to the ﬁndings of Sit-
nik et al.,5 who detected 62% (31/50). However, this rate differs
from  the results of De Castro et al.,16 who found a frequency
of  20% (2/10). The frequency of these mutations was  simi-
lar  among asymptomatic individuals and those with chronic
hepatitis  despite ALT serum level and viral load, and its pres-
ence  seemed not to interfere with the clinical course of HBV
infections.
However,  in studies with other genotypes, BCP mutations
have  been correlated with greater activity and high frequency
of  chronic hepatitis B. These mutations are considered to be
one  of the independent predictive viral factors for the risk of
developing  hepatocellular carcinoma.16
In conclusion, in this ﬁrst molecular study of HBV in
Alagoas, we could demonstrate that investigation of HBV
genotypes  is important to both broadening the information
about its geographical distribution and assessing its impor-
tance  in the virus–host relation. Our results contributed to
knowledge  regarding the HBV genotypes in the State of
Alagoas,  Brazil, which can also be a reference for further inves-
tigations.
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